| http://purl.uniprot.org/citations/34266470 | http://www.w3.org/1999/02/22-rdf-syntax-ns#type | http://purl.uniprot.org/core/Journal_Citation |
| http://purl.uniprot.org/citations/34266470 | http://www.w3.org/2000/01/rdf-schema#comment | "BackgroundMyalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a serious multifactorial disorder. The origin remains ambiguous, however reduced natural killer (NK) cell cytotoxicity is a consistent immunological feature of ME/CFS. Impaired transient receptor potential melastatin 3 (TRPM3), a phosphatidylinositol dependent channel, and impaired calcium mobilisation have been implicated in ME/CFS pathology. This investigation aimed to examine the localisation of TRPM3 at the NK cell plasma membrane and co-localisation with phosphatidylinositol 4,5-bisphosphate (PIP2). The effect of IL-2 priming and treatment using pregnenolone sulfate (PregS) and ononetin on TRPM3 co-localisation and NK cell cytotoxicity in ME/CFS patients and healthy controls (HC) was also investigated.MethodsNK cells were isolated from 15 ME/CFS patients and 15 age- and sex-matched HC. Immunofluorescent technique was used to determine co-localisation of TRPM3 with the NK cell membrane and with PIP2 of ME/CFS patients and HC. Flow cytometry was used to determine NK cell cytotoxicity. Following IL-2 stimulation and treatment with PregS and ononetin changes in co-localisation and NK cell cytotoxicity were measured.ResultsOvernight treatment of NK cells with PregS and ononetin resulted in reduced co-localisation of TRPM3 with PIP2 and actin in HC. Co-localisation of TRPM3 with PIP2 in NK cells was significantly reduced in ME/CFS patients compared with HC following priming with IL-2. A significant increase in co-localisation of TRPM3 with PIP2 was reported following overnight treatment with ononetin within ME/CFS patients and between groups. Baseline NK cell cytotoxicity was significantly reduced in ME/CFS patients; however, no changes were observed following overnight incubation with IL-2, PregS and ononetin between HC and ME/CFS patients. IL-2 stimulation significantly enhanced NK cell cytotoxicity in HC and ME/CFS patients.ConclusionSignificant changes in co-localisation suggest PIP2-dependent TRPM3 function may be impaired in ME/CFS patients. Stimulation of NK cells with IL-2 significantly enhanced cytotoxic function in ME/CFS patients demonstrating normal function compared with HC. A crosstalk exists between IL-2 and TRPM3 intracellular signalling pathways which are dependent on Ca2+ influx and PIP2. While IL-2R responds to IL-2 binding in vitro, Ca2+ dysregulation and impaired intracellular signalling pathways impede NK cell function in ME/CFS patients."xsd:string |
| http://purl.uniprot.org/citations/34266470 | http://purl.org/dc/terms/identifier | "doi:10.1186/s12967-021-02974-4"xsd:string |
| http://purl.uniprot.org/citations/34266470 | http://purl.uniprot.org/core/author | "Marshall-Gradisnik S."xsd:string |
| http://purl.uniprot.org/citations/34266470 | http://purl.uniprot.org/core/author | "Staines D."xsd:string |
| http://purl.uniprot.org/citations/34266470 | http://purl.uniprot.org/core/author | "Cabanas H."xsd:string |
| http://purl.uniprot.org/citations/34266470 | http://purl.uniprot.org/core/author | "Eaton-Fitch N."xsd:string |
| http://purl.uniprot.org/citations/34266470 | http://purl.uniprot.org/core/author | "du Preez S."xsd:string |
| http://purl.uniprot.org/citations/34266470 | http://purl.uniprot.org/core/date | "2021"xsd:gYear |
| http://purl.uniprot.org/citations/34266470 | http://purl.uniprot.org/core/name | "J Transl Med"xsd:string |
| http://purl.uniprot.org/citations/34266470 | http://purl.uniprot.org/core/pages | "306"xsd:string |
| http://purl.uniprot.org/citations/34266470 | http://purl.uniprot.org/core/title | "The effect of IL-2 stimulation and treatment of TRPM3 on channel co-localisation with PIP2 and NK cell function in myalgic encephalomyelitis/chronic fatigue syndrome patients."xsd:string |
| http://purl.uniprot.org/citations/34266470 | http://purl.uniprot.org/core/volume | "19"xsd:string |
| http://purl.uniprot.org/citations/34266470 | http://www.w3.org/2004/02/skos/core#exactMatch | http://purl.uniprot.org/pubmed/34266470 |
| http://purl.uniprot.org/citations/34266470 | http://xmlns.com/foaf/0.1/primaryTopicOf | https://pubmed.ncbi.nlm.nih.gov/34266470 |
| http://purl.uniprot.org/uniprot/#_A0A023JDW0-mappedCitation-34266470 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/34266470 |
| http://purl.uniprot.org/uniprot/#_E9PBI7-mappedCitation-34266470 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/34266470 |
| http://purl.uniprot.org/uniprot/#_A2A3F4-mappedCitation-34266470 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/34266470 |
| http://purl.uniprot.org/uniprot/#_G5E9G1-mappedCitation-34266470 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/34266470 |
| http://purl.uniprot.org/uniprot/#_H7BYP1-mappedCitation-34266470 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/34266470 |
| http://purl.uniprot.org/uniprot/#_Q504Y1-mappedCitation-34266470 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/34266470 |
| http://purl.uniprot.org/uniprot/#_Q9HCF6-mappedCitation-34266470 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/34266470 |
| http://purl.uniprot.org/uniprot/#_Q9H200-mappedCitation-34266470 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/34266470 |
| http://purl.uniprot.org/uniprot/#_Q6NW43-mappedCitation-34266470 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/34266470 |
| http://purl.uniprot.org/uniprot/#_Q8TBK0-mappedCitation-34266470 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/34266470 |